Inogen (INGN) Share-based Compensation (2013 - 2026)
Inogen's (INGN) quarterly Share-based Compensation came in at $2.0 million in Q1 2026, up 242.11% year-on-year from $570000.0 in Q1 2025, and up 136.23% on a QoQ basis from -$5.4 million in Q4 2025.
Inogen (INGN) Share-based Compensation (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Share-based Compensation data on file, last reported at $2.0 million in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 242.11% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $624000.0, a 148.0% increase from a year earlier, with the FY2025 full-year figure at $821000.0, up 50.37% from the prior year.
- Share-based Compensation for Q1 2026 stood at $2.0 million, up from -$5.4 million in the prior quarter.
- Over the last five years, Share-based Compensation for INGN reached as high as $11.0 million in Q4 2022 and fell as low as -$5.4 million in Q4 2025.
- Historically, Share-based Compensation has averaged $2.1 million across 5 years, with a median of $2.0 million in 2026.
- Across the five-year window, Share-based Compensation plunged 174.51% in 2024 and jumped 570.59% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $11.0 million in 2022, then plunged by 37.34% to $6.9 million in 2023, then tumbled by 174.51% to -$5.2 million in 2024, then retreated by 4.34% to -$5.4 million in 2025, then jumped by 136.23% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $2.0 million in Q1 2026, -$5.4 million in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 1.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.95 Mn |
| Mar 31, 2026 | 1.95 Mn |
| Dec 31, 2025 | -5.38 Mn |
| Dec 31, 2025 | -5.38 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 570,000.00 |
| Mar 31, 2025 | 570,000.00 |
| Dec 31, 2024 | -5.16 Mn |
| Dec 31, 2024 | -5.16 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | 85,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Dec 31, 2023 | 6.92 Mn |
| Dec 31, 2023 | 6.92 Mn |